BMC CANCER, vol.17, 2017 (Journal Indexed in SCI)
Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.